Breaking News, Promotions & Moves

Executive Moves at Gilead

Dr. Cheng and Dr. Yang join the senior leadership committee

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Andrew Cheng, MD, Ph.D., has been appointed executive vice president, HIV Therapeutics and Development Operations at Gilead Sciences, and Taiyin Yang, Ph.D., has been appointed executive vice president, Pharmaceutical Development and Manufacturing. Both Dr. Cheng and Dr. Yang will join the senior leadership committee.   Dr. Cheng joined the company in 1999 and has led clinical development activities for development-stage programs in HIV/AIDS. In 2009, he was appointed senior vice president, HIV ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters